Courtney Breen
Stock Analyst at Bernstein
(0.37)
# 4,295
Out of 5,141 analysts
4
Total ratings
n/a
Success rate
-3.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Courtney Breen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Downgrades: Market Perform | $335 | $374.75 | -10.61% | 1 | Jan 20, 2026 | |
| LLY Eli Lilly and Company | Maintains: Outperform | $1,100 → $1,300 | $1,009.52 | +28.77% | 1 | Nov 24, 2025 | |
| MRNA Moderna | Initiates: Market Perform | $55 | $49.87 | +10.29% | 1 | Oct 17, 2024 | |
| PFE Pfizer | Initiates: Market Perform | $32 | $26.65 | +20.08% | 1 | Oct 17, 2024 |
Amgen
Jan 20, 2026
Downgrades: Market Perform
Price Target: $335
Current: $374.75
Upside: -10.61%
Eli Lilly and Company
Nov 24, 2025
Maintains: Outperform
Price Target: $1,100 → $1,300
Current: $1,009.52
Upside: +28.77%
Moderna
Oct 17, 2024
Initiates: Market Perform
Price Target: $55
Current: $49.87
Upside: +10.29%
Pfizer
Oct 17, 2024
Initiates: Market Perform
Price Target: $32
Current: $26.65
Upside: +20.08%